Featured Stories

Expanded Immunology Services

08/12/2014

Our Edinburgh site has just moved its cell-based assay work into new laboratory facilities and has been developing new approaches in neutralizing antibody (NAb) and antibody-dependent cell-mediated cytotoxicity (ADCC) assays.

Translational Asthma In Vivo Models

08/08/2014

With the acquisition of Argenta earlier this year, Charles River's asthma expertise and portfolio has expanded to include unique models that reflect the clinical setting.

Charles River to Maintain the Frederick NCI Facility

07/21/2014

As of today, Charles River will assume management and operational responsibilities for the Frederick facility and we will continue to breed and maintain the colonies that are currently housed at this facility.

Argenta and BioFocus Have a New Home at www.criver.com

06/12/2014

We are pleased to inform you that www.argentadiscovery.com and www.biofocus.com are now incorporated into the Charles River website, providing you with integrated discovery services information in a single location.

Reinforcing Our Commitment to Humane Care

06/09/2014

On May 14, we furthered our commitment to the humane care of research animals by joining our industry colleagues in the signing of the final Concordat on Openness on Animal Research in the UK. 

Displaying results 1-10 (of 116)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >|